Unlike blood oxygenation level dependent (BOLD) fMRI, which we previously used to probe DAT in our Type 1 diabetes mellitus model [5], the advantages of CBV fMRI include the quantification of a physiological parameter that represents an indirect measure of neural activation and a larger signal window of response. Here, SLC6A3 is linked to diabetes mellitus.